|
Name |
Fusaricidin A
|
Molecular Formula | C41H74N10O11 | |
IUPAC Name* |
N-[(3R,6R,9R,12S,15R,18S,19R)-6-(2-amino-2-oxoethyl)-9-[(1R)-1-hydroxyethyl]-3,19-dimethyl-2,5,8,11,14,17-hexaoxo-12,15-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]-15-(diaminomethylideneamino)-3-hydroxypentadecanamide
|
|
SMILES |
C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)O1)C)CC(=O)N)[C@@H](C)O)C(C)C)C(C)C)NC(=O)CC(CCCCCCCCCCCCN=C(N)N)O
|
|
InChI |
InChI=1S/C41H74N10O11/c1-22(2)31-36(57)49-32(23(3)4)37(58)51-33(25(6)52)38(59)47-28(21-29(42)54)35(56)46-24(5)40(61)62-26(7)34(39(60)50-31)48-30(55)20-27(53)18-16-14-12-10-8-9-11-13-15-17-19-45-41(43)44/h22-28,31-34,52-53H,8-21H2,1-7H3,(H2,42,54)(H,46,56)(H,47,59)(H,48,55)(H,49,57)(H,50,60)(H,51,58)(H4,43,44,45)/t24-,25-,26-,27?,28-,31-,32+,33-,34+/m1/s1
|
|
InChIKey |
ZQMLIVBQFXSJNR-NVCIGDDDSA-N
|
|
Synonyms |
Fusaricidin A; SCHEMBL629339; N-[(3R,6R,9R,12S,15R,18S,19R)-6-(2-amino-2-oxoethyl)-9-[(1R)-1-hydroxyethyl]-3,19-dimethyl-2,5,8,11,14,17-hexaoxo-12,15-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]-15-(diaminomethylideneamino)-3-hydroxypentadecanamide
|
|
CAS | NA | |
PubChem CID | 21581469 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 883.1 | ALogp: | 2.3 |
HBD: | 11 | HBA: | 12 |
Rotatable Bonds: | 21 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 349.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 62 | QED Weighted: | 0.029 |
Caco-2 Permeability: | -5.817 | MDCK Permeability: | 0.00005010 |
Pgp-inhibitor: | 0.555 | Pgp-substrate: | 1 |
Human Intestinal Absorption (HIA): | 0.855 | 20% Bioavailability (F20%): | 0.987 |
30% Bioavailability (F30%): | 0.994 |
Blood-Brain-Barrier Penetration (BBB): | 0.052 | Plasma Protein Binding (PPB): | 67.60% |
Volume Distribution (VD): | 0.465 | Fu: | 24.77% |
CYP1A2-inhibitor: | 0 | CYP1A2-substrate: | 0.007 |
CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.035 |
CYP2C9-inhibitor: | 0.061 | CYP2C9-substrate: | 0.002 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.032 |
CYP3A4-inhibitor: | 0.086 | CYP3A4-substrate: | 0.06 |
Clearance (CL): | 2.935 | Half-life (T1/2): | 0.361 |
hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.956 |
Drug-inuced Liver Injury (DILI): | 0.113 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.004 | Maximum Recommended Daily Dose: | 0.085 |
Skin Sensitization: | 0.043 | Carcinogencity: | 0.006 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.002 |
Respiratory Toxicity: | 0.006 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002057 | 0.936 | D02SBQ | 0.350 | ||||
ENC003716 | 0.803 | D0K7NQ | 0.339 | ||||
ENC003684 | 0.755 | D00ZCN | 0.338 | ||||
ENC005275 | 0.484 | D0D8XY | 0.333 | ||||
ENC003950 | 0.472 | D09OOV | 0.317 | ||||
ENC005272 | 0.461 | D07FEC | 0.316 | ||||
ENC005273 | 0.459 | D05HPI | 0.305 | ||||
ENC005274 | 0.434 | D0M3FJ | 0.303 | ||||
ENC005271 | 0.419 | D08FJL | 0.288 | ||||
ENC001983 | 0.416 | D0J7XL | 0.285 |